Publications by authors named "L Minig"
Objective: To assess the safety of fertility-sparing treatments for early-stage ovarian cancer in women younger than 40 years old.
Methods: We performed a retrospective multicenter study including women aged 18-40 years diagnosed with early-stage (FIGO I-II) ovarian cancer in 55 Spanish hospitals, from January 2010 to December 2019. Benign and borderline tumors were excluded, as well as advanced stages (FIGO III-IV).
Background: to prove the effectivity of fertility-sparing procedures in early-stage ovarian cancer by assessing pregnancy rates and obstetrical outcomes.
Methods: we performed a retrospective multicenter study among 55 Spanish hospitals, collecting patients from 18 to 40 years old with diagnosis of early-stage ovarian cancer, epithelial (EOC) or non-epithelial (non-EOC), from January 2010 to December 2019. Data on the use of assisted reproductive techniques, pregnancy attempts and obstetrical outcomes were collected.
Article Synopsis
- Researchers looked at two blood tests, procalcitonin and CRP, to see if they could help predict problems after surgery for advanced ovarian cancer.
- They studied 92 patients and found that higher levels of these markers were linked to a condition called anastomotic leakage, where the surgical connections in the bowel may fail.
- The best time to check these blood tests for accurate results was found to be day 1 for procalcitonin and day 3 for CRP after surgery.
Objective: To determine oncological outcomes and to identify prognostic factors in women aged <45 years with epithelial ovarian cancer.
Methods: A multicenter retrospective study was performed of patients treated for epithelial ovarian cancer aged <45 years between January 2010 and December 2019.
Results: A total of 998 patients with epithelial ovarian cancer from 55 different institutions in Spain were collected.
Objective: To determine oncological outcomes and associated prognostic factors in women younger than 45 years diagnosed with non-epithelial ovarian cancer.
Methods: A retrospective, multicenter Spanish study was performed including women with non-epithelial ovarian cancer younger than 45 years between January 2010 and December 2019. All types of treatments and stages at diagnosis with at least 12 months of follow-up were collected.